In brief: GTG, Resonance Health, Sirtex

By Ruth Beran
Thursday, 07 July, 2005

Genetic Technologies (ASX:GTG) has settled all of its disputes with the Auckland District Health Board, as the representative of all the New Zealand district health boards plus the New Zealand Blood Service. The disputes related to lawsuits filed in New Zealand in 2004 by ADHB against Genetic Technologies' non-coding DNA analysis patent and genomic mapping patent.

Resonance Health (ASX:RHT) has expanded its Medical Advisory Board with new members Dr Bruce Bacon, Dr John Olynyk and Dr John Porter joining current member Dr Kris Kowdley. Dr Chris Bennett has resigned from her position on the former Inner Vision Biometrics Medical Advisory Board but remains as a non-executive director of Resonance Health.

Sirtex Medical (ASX:SRX) has appointed Angela Talbot as its chief financial officer.

Related News

'Low-risk' antibiotic linked to rise of dangerous superbug

A new study has challenged the long-held belief that rifaximin — commonly prescribed to...

Robotic hand helps cultivate baby corals for reef restoration

The soft robotic hand could revolutionise the delicate, labour-intensive process of cultivating...

Stem cell experiments conducted in space

Scientists are one step closer to manufacturing stem cells in space — which could speed up...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd